IMMUNOME Trademark

Trademark Overview

On Friday, September 13, 2024, a trademark application was filed for IMMUNOME with the United States Patent and Trademark Office. The USPTO has given the IMMUNOME trademark a serial number of 98749939. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Friday, September 19, 2025. This trademark is owned by Immunome, Inc.. The IMMUNOME trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of oncological related diseases and disorders
immunome

General Information

Serial Number98749939
Word MarkIMMUNOME
Filing DateFriday, September 13, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateFriday, September 19, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of oncological related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 13, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameImmunome, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBothell, WA 98011

Trademark Events

Event DateEvent Description
Friday, September 13, 2024NEW APPLICATION ENTERED
Friday, September 13, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 13, 2025ASSIGNED TO EXAMINER
Tuesday, March 18, 2025NON-FINAL ACTION E-MAILED
Tuesday, March 18, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 18, 2025NON-FINAL ACTION WRITTEN
Thursday, September 18, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 18, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 19, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 18, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, June 18, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Related Keywords

immunome related diseases disorders oncological treatment preparations substances pharmaceutical